You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 5, August 4, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentaries
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Biological Defense Research: Charting a Safer Course

Jay A. Jacobson, MD; Barbara Hatch Rosenberg, PhD

JAMA. 1989;262(5):675-676.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ARMY'S research on biological agents has escalated dramatically since 1980 and raised concerns in the scientific and medical communities about its propriety, utility, and safety. In an article in this issue of THE JOURNAL regarding chemical and biological warfare, Orient1 asks whether defenses should be researched. Defenses are, of course, being researched, but some of this research may undermine the 1972 Biological and Toxin Weapons Convention, which bans the use and development of biological weapons. We will comment on some aspects of the current US Biological Defense Research Program and suggest ways that physicians can be sure that research on biological agents, if it is necessary, is safe, appropriate, and likely to decrease rather than increase the threat of a biological arms race. We propose changes in responsibility for some biological defense research, more openness in the conduct of research, and reinforcement of the 1972 treaty.

The basis . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Internal Medicine, University of Utah, and the Division of Infectious Diseases, Latter-Day Saints Hospital, Salt Lake City (Dr Jacobson) and the Memorial-Sloan Kettering Cancer Center, Walker Laboratory, Rye, NY (Dr Rosenberg).


Footnotes

Reprint requests to the Division of Infectious Diseases, Latter-Day Saints Hospital, Eighth Avenue and C Street, Salt Lake City, UT 84143 (Dr Jacobson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.